Literature DB >> 26562162

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Christoph Jindra, Bettina Huber, Saeed Shafti-Keramat, Markus Wolschek, Boris Ferko, Thomas Muster, Sabine Brandt, Reinhard Kirnbauer.   

Abstract

Entities:  

Year:  2015        PMID： 26562162      PMCID： PMC4642983          DOI： 10.1371/journal.pone.0143269

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There is an error throughout the Methods section of this manuscript. The virus concentration is recorded incorrectly as 3.75 log TCID50. The correct concentration is 7.2 log TCID50.
  1 in total

1.  Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Authors:  Christoph Jindra; Bettina Huber; Saeed Shafti-Keramat; Markus Wolschek; Boris Ferko; Thomas Muster; Sabine Brandt; Reinhard Kirnbauer
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240
  1 in total
  1 in total

1.  Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.

Authors:  Christoph Jindra; Edmund K Hainisch; Andrea Rümmele; Markus Wolschek; Thomas Muster; Sabine Brandt
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.